Prior view was 6%-7%. Sees FY23 operational sales growth 7.5%-8.5% vs. prior 7%-8%. FY23 revenue consensus $100.23B. Guidance excludes Consumer Health.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on JNJ: